TSHR基因突变所致先天性甲状腺功能异常的临床研究
Clinical Study of Congenital Thyroid Dysfunction Caused by TSHR Gene Mutation
摘要: 研究发现,促甲状腺激素受体(thyroid stimulating hormone receptor, TSHR)基因突变可导致甲状腺结构或功能异常。TSHR基因突变所致先天性甲状腺功能异常临床表型与突变类型高度异质,重者可危及生命或遗留不可逆后遗症;轻者可无临床症状,仅表现为生化水平的甲状腺功能异常。为避免严重并发症或后遗症发生,需做到早发现、早诊断、早治疗。为了增强对TSHR基因突变所致先天性甲状腺功能异常疾病的认识,本文将从甲状腺激素(thyroid hormone, TH)的产生与功能、TSHR的结构、突变类型及TSHR基因突变所致原发性先天性甲状腺功能异常的临床表现、诊断及治疗等方面进行综述。
Abstract: Studies have found that mutations in the thyroid stimulating hormone receptor (TSHR) gene can lead to abnormal thyroid structure or function. The clinical phenotype and mutation type of con-genital thyroid dysfunction caused by TSHR gene mutation are highly heterogeneous; severe cases may be life-threatening or have irreversible sequelae; mild cases may be asymptomatic, only showing thyroid dysfunction at the biochemical level. In order to avoid serious complications or se-quelae, it is important to detect, diagnose and treat these diseases as early as possible. The synthe-sis and function of thyroid hormone, the structure and mutation types of TSHR, and the clinical manifestations, diagnosis and treatments of thyroid dysfunction caused by TSHR gene mutations were reviewed, to enhance the understanding of these diseases.
文章引用:陈永琴, 朱岷. TSHR基因突变所致先天性甲状腺功能异常的临床研究[J]. 临床医学进展, 2022, 12(5): 3861-3865. https://doi.org/10.12677/ACM.2022.125558

参考文献

[1] Zhang, H.M., et al. (2017) Identification and Functional Characterization of a Novel Thyrotropin Receptor Mutation (V87L) in a Chinese Woman with Subclinical Hypothyroidism. Experimental and Therapeutic Medicine, 13, 290-294. [Google Scholar] [CrossRef] [PubMed]
[2] Ortiga-Carvalho, T.M., et al. (2016) Hypothalamus-Pituitary-Thyroid Axis. Comprehensive Physiology, 6, 1387-1428. [Google Scholar] [CrossRef] [PubMed]
[3] Wassner, A.J. (2017) Pediatric Hypothyroidism: Diagnosis and Treat-ment. Pediatric Drugs, 19, 291-301. [Google Scholar] [CrossRef] [PubMed]
[4] 武银铃, 李红宁, 刘国良. 基因突变及先天性甲状腺功能低下症(甲状腺形态发育异常) [J]. 实用糖尿病杂志, 2019, 15(5): 3-5.
[5] Paschke, R., et al. (2012) 2012 European Thyroid Association Guidelines for the Management of Familial and Persistent Sporadic Non-Autoimmune Hyperthy-roidism Caused by Thyroid-Stimulating Hormone Receptor Germline Mutations. European Thyroid Journal, 1, 142-147. [Google Scholar] [CrossRef] [PubMed]
[6] Nguyen, J. and Joseph, D. (2022) Locally Invasive Classical Papillary Thyroid Carcinoma with TSH Receptor I568T Mutation: Case Report. Endocrinology, Diabetes & Metabolism Case Re-ports, 2022. [Google Scholar] [CrossRef
[7] Wang, H., et al. (2020) Mutation Spectrum Analysis of 29 Causative Genes in 43 Chinese Patients with Congenital Hypothyroidism. Molecular Medicine Reports, 22, 297-309. [Google Scholar] [CrossRef] [PubMed]
[8] Sugisawa, C., et al. (2018) Identification of Compound Heterozy-gous TSHR Mutations (R109Q and R450H) in a Patient with Nonclassic TSH Resistance and Functional Characteriza-tion of the Mutant Receptors. Clinical Pediatric Endocrinology, 27, 123-130. [Google Scholar] [CrossRef] [PubMed]
[9] Fuhrer, D. (2020) Constitutive TSH Receptor Activation as a Hallmark of Thyroid Autonomy. Endocrine, 68, 274-278. [Google Scholar] [CrossRef] [PubMed]
[10] Long, W., et al. (2018) Targeted Next-Generation Sequencing of Thirteen Causative Genes in Chinese Patients with Congenital Hypothyroidism. Endocrine Journal, 65, 1019-1028. [Google Scholar] [CrossRef
[11] Watanabe, D., et al. (2020) A Novel c.1391_1428delinsT Mutation in TSHR as a Cause of Familial Congenital Hypothyroidism with Delayed Onset. Pediatrics & Neonatology, 61, 114-116. [Google Scholar] [CrossRef] [PubMed]
[12] Suput, O.J., et al. (2021) Central TSH Dysregulation in a Patient with Familial Non-Autoimmune Autosomal Dominant Hyperthyroidism Due to a Novel Thyroid-Stimulating Hormone Receptor Disease-Causing Variant. Medicina (Kaunas), 57, 196. [Google Scholar] [CrossRef] [PubMed]
[13] Kayas, L., et al. (2022) TSHRV656F Activating Variant of the Thyroid Stimulating Hormone Receptor Gene in Neonatal Onset Hyperthyroidism: A Case Review. Journal of Clinical Research in Pediatric Endocrinology, 14, 114-118. [Google Scholar] [CrossRef] [PubMed]
[14] Cassio, A., et al. (2013) Current Loss-of-Function Mu-tations in the Thyrotropin Receptor Gene: When to Investigate, Clinical Effects, and Treatment. Journal of Clinical Re-search in Pediatric Endocrinology, 5, 29-39.
[15] Larsen, C.C., et al. (2014) A New Family with an Activating Muta-tion (G431S) in the TSH Receptor Gene: A Phenotype Discussion and Review of the Literature. International Journal of Pediatric Endocrinology, 2014, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[16] Duprez, L., et al. (1994) Germline Mutations in the Thyrotropin Receptor Gene Cause Non-Autoimmune Autosomal Dominant Hyperthyroidism. Nature Genetics, 7, 396-401. [Google Scholar] [CrossRef] [PubMed]
[17] Vaidya, B., et al. (2004) Premature Birth and Low Birth Weight Associ-ated with Nonautoimmune Hyperthyroidism Due to an Activating Thyrotropin Receptor Gene Mutation. Clinical Endo-crinology (Oxford), 60, 711-718. [Google Scholar] [CrossRef] [PubMed]
[18] Chawla, R., et al. (2015) Squamosal Suture Cranio-synostosis Due to Hyperthyroidism Caused by an Activating Thyrotropin Receptor Mutation (T632I). Thyroid, 25, 1167-1172. [Google Scholar] [CrossRef] [PubMed]
[19] Ahn, M.B. (2021) Extrathyroidal Manifestations of Persis-tent Sporadic Non-Autoimmune Hyperthyroidism in a 6-Year-Old Boy: A Case Report. Life (Basel), 11, 713. [Google Scholar] [CrossRef] [PubMed]
[20] Wong, F.C., et al. (2018) False-Positive TSH Receptor Antibody Results in an Infant with Activating TSHR Mutation. Endocrine Journal, 65, 793-794. [Google Scholar] [CrossRef
[21] Fuhrer, D., et al. (2000) Novel TSHR Germline Mutation (Met463Val) Masquerading as Graves’ Disease in a Large Welsh Kindred with Hyperthyroidism. Thyroid, 10, 1035-1041. [Google Scholar] [CrossRef] [PubMed]
[22] van Trotsenburg, P., et al. (2021) Congenital Hypothy-roidism: A 2020-2021 Consensus Guidelines Update—An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology. Thyroid, 31, 387-419. [Google Scholar] [CrossRef] [PubMed]
[23] 罗俊, 吴素英. 先天性甲状腺功能减低症研究进展[J]. 世界最新医学信息文摘, 2019, 19(96): 48-49.
[24] Wassner, A.J. and Brown, R.S. (2015) Congenital Hypothyroidism: Recent Advances. Current Opinion in Endocrinology, Diabetes and Obesity, 22, 407-412. [Google Scholar] [CrossRef
[25] Brown, R.S., Alter, C.A. and Sadeghi-Nejad, A. (2015) Severe Unsuspected Maternal Hypothyroidism Discovered after the Diagnosis of Thyrotropin Receptor-Blocking Anti-body-Induced Congenital Hypothyroidism in the Neonate: Failure to Recognize and Implications to the Fetus. Hormone Research in Paediatrics, 83, 132-135. [Google Scholar] [CrossRef] [PubMed]
[26] Patel, K.A., et al. (2019) Utility of Systematic TSHR Gene Testing in Adults with Hyperthyroidism Lacking overt Autoimmunity and Diffuse Uptake on Thyroid Scintigraphy. Clinical Endo-crinology (Oxford), 90, 328-333. [Google Scholar] [CrossRef] [PubMed]